<DOC>
	<DOCNO>NCT01648686</DOCNO>
	<brief_summary>The purpose study determine whether oral alendronate treatment post-menopausal osteoporosis could risk factor jaw bone heal dental extraction .</brief_summary>
	<brief_title>Bone Healing After Dental Extraction Postmenopausal Osteoporotic Women Treated With Alendronate Per os Weekly</brief_title>
	<detailed_description>Alendronate main oral bisphosphonate use treatment prevention postmenopausal osteoporosis high antiresorbant ability bone tissue . Alendronate delay bone heal dental extraction animal model , murine canine . Anti-angiogenic anti-osteoclastic characteristic suggest explain phenomenon . There available data human well know bisphosphonates involve occurrence osteonecrosis jaw even major adverse effect seem seldom oral alendronate . Moreover , bisphosphonate show toxicity oral mucosal cell . The main aim study quantify impact oral alendronate weekly treatment bone mucosa heal dental extraction postmenopausal osteoporotic woman . A secondary aim investigate panel 50 peptids potentially involve bone mucosal heal detect change rate salivary proteomic approach . The investigator hope identify salivary biomarkers bone and/or mucosa heal woman . Our hypothesis dental extraction , bone healing could delay postmenopausal osteoporotic woman treat oral weekly alendronate ( BP+ group ) versus match osteoporotic woman untreated bisphosphonates ( BP- group ) . This prospective multicentric ( 17 investigation center dispatch France ) study include 140 osteoporotic postmenopausal woman treat weekly oral bisphosphonates ( BP+ group ) 140 osteoporotic postmenopausal woman untreated bisphosphonates ( BP- group ) . This clinical follow-up study ( T0 , T0 + 7 , T0 + 30 , T0 + 90 day ) , radiological study ( T0 , T0 + 30 , T0 + 90 day ) , salivary proteomic study ( T0 , T0 + 30 , T0 + 90 day ) . This 4 year study start april 2012 ( anticipated date ) . The main investigated parameter : - Bone healing : Bone fill rate ( % ) post-extractional alveolar socket ( BFR ) T0 , T0 + 30 T0 + 90 day radiographic approach . - Mucosa healing : mucosal injury metric approach T0 T0 + 30 day . - Salivary biomarkers : Fifty peptides proteomic approach T0 T0 + 30 day ; The investigator expect study allow u build reference scale bone mucosa heal osteoporotic postmenopausal woman treat weekly oral alendronate . This scale helpful tool dental physician . The investigator hope also identify salivary biomarkers variation make diagnosis prognosis tool bad bone heal patient . Perspectives study constitute national network deleterious effect bone heal woman patient up-date guideline area .</detailed_description>
	<mesh_term>Alendronate</mesh_term>
	<mesh_term>Diphosphonates</mesh_term>
	<criteria>Postmenopausal osteoporotic woman Treated alendronate per o ( 70 pg weekly ) BP+ experimental group untreated therapy BP Control group Subjected single root tooth extraction 45 70 year age Maxillofacial irradiation Dental extraction adjunction material interfere bone heal Severe pathology inconsistent study Bisphosphonate treatment BP control group Women treat denosumab ( proliaÂ® ) Women already include another dental extraction</criteria>
	<gender>Female</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Alendronate</keyword>
	<keyword>Dental extraction</keyword>
	<keyword>Bone healing</keyword>
	<keyword>postmenopausal woman</keyword>
	<keyword>dental radiography</keyword>
</DOC>